Mental Health Issues in the COVID-19 Pandemic: July 2020

3.00 CME
180 MINS
$30 FEE
SAVE
OGI

Table of Contents

Development of a Virtual Consultation-Liaison Psychiatry Service: A Multifaceted Transformation

Rachel A. Caravella, MD; Allison B. Deutch, MD; Paraskevi Noulas, PsyD; Patrick Ying, MD; K. Ron-Li Liaw, MD; Jeanne Greenblatt, MD, MPH; Kelsey Collins, MD, MS; H. K. Eastburn, RN-BC, MS, PMHNP; Emily Fries, BSN, RN-BC; Shabana Khan, MD; Adam Kozikowski, MS, NP-P, PMHNP-BC; S. Alex Sidelnik, MD; Michael Yee, MD; and David Ginsberg, MD

Development of Wellness Programs During the COVID-19 Pandemic Response

Amanda M. Spray, PhD; Nikhil A. Patel, MD, MPH, MS; Ashvin Sood, MD; Stephanie X. Wu, BA; Naomi M. Simon, MD, MSc; Rachel Podbury, BPubHealth&HealthProm; Ariela Vasserman, PsyD; Rachel A. Caravella, MD; Yona Silverman, MD; Randi Pochtar, PhD; K. Ron-Li Liaw, MD; and Marra G. Ackerman, MD

Acute Stress Disorder and the COVID-19 Pandemic

Sharon B. Madanes, MD, MFA; Rose Levenson-Palmer, PhD; Kristin L. Szuhany, PhD; Matteo Malgaroli, PhD; Emma L. Jennings, BS; Deepti Anbarasan, MD; and Naomi M. Simon, MD, MSc

Guidelines for Redeploying Psychiatrists to Medicine During a Pandemic Crisis

Paula Askalsky, MD; Rahn K. Bailey, MD; Edward M. Kantor, MD; Frederick J. Stoddard Jr., MD; James C. West, MD; and Charles R. Marmar, MD

Sponsorship Statement: This CME activity is jointly sponsored by AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals.

Support Statement: There is no commercial support for this activity.

Learning Objectives:

  1. Describe methods to reduce exposure to COVID-19 during routine psychiatric consultations or behavioral emergencies.
  2. Describe three main modalities of support provided to staff at a major health system in the wake of the COVID-19 pandemic.
  3. Describe principles of trauma, risk and resilience, acute stress disorder, other stress responses, and appropriate interventions as they relate to the COVID-19 pandemic.
  4. Understand key decisions involved in the redeployment of psychiatrists during a global pandemic.

Author names and affiliations:  See authors above

Guest Editor: Lenard A. Adler, MD

Reviewer names:  Andrew A. Nierenberg, MD, Editor, and Lenard A. Adler, MD, CME Coordinator, Psychiatric Annals

Disclosure statement:  In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears at the beginning of each CME-accredited article in this issue and also on this page.

Faculty members report the following financial relationships:  Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly and Company; EpiQ, Forest; Johnson and Johnson; Labopharm; Merck; Methylation Science; Novartis; PamLabs; PGx Health; Shire; Schering-Plough; Sunovion; Takeda/Lundbeck Pharmaceuticals; Targacept; Teva: Consultant. APSARD; Belvoir Publishing; Boston Center for the Arts; University of Texas Southwestern Dallas; Hillside Hospital; American Drug Utilization Review; American Society for Clinical Psychopharmacology; Bayamon Region Psychiatric Society; Baystate Medical Center; Canadian Psychiatric Association; Columbia University; Douglas Hospital/McGill University; IMEDEX; International Society for Bipolar Disorders; Israel Society for Biological Psychiatry; John Hopkins University; MJ Consulting; Massachusetts Association of College Counselors; Medscape; MBL Publishing; Physicians Postgraduate Press; Ryan Licht Sang Foundation; Slack Publishing; SUNY Buffalo; University of Florida; University of Miami; University of Wisconsin; University of Pisa; SciMed: Honoraria / travel expenses. Appliance Computing, Inc.; Brain Cells, Inc.: Stock options. AHRQ; Cephalon; Forest; Mylan; NIMH; PamLabs; Pfizer Pharmaceuticals; Takeda; Elan; Shire: Grant / research support.
Lenard A. Adler has disclosed the following relevant financial relationships: research grants paid to New York University (NYU) on Dr. Adler’s behalf from Sunovion Pharmaceuticals, Shire Pharmaceuticals, Lundbeck, Enzymotec, Purdue Pharma; personal fees for consulting or advisory boards from Sunovion Pharmaceuticals, Enzymotec, Shire Pharmaceuticals, the National Football League, Major League Baseball, Shire Pharmaceuticals, Otsuka Pharmaceuticals, Alcobra Pharmaceuticals; and royalty fees from NYU School of Medicine for license of Adult ADHD rating scales and training materials.

Authors report the following financial relationships: Rachel A. Caravella has no relevant financial relationships to disclose. Allison B. Deutch has no relevant financial relationships to disclose. Paraskevi Noulas has no relevant financial relationships to disclose. Patrick Ying has no relevant financial relationships to disclose. K. Ron-Li Liaw has no relevant financial relationships to disclose. Jeanne Greenblatt has no relevant financial relationships to disclose. Kelsey Collins has no relevant financial relationships to disclose. H.K. Eastburn has no relevant financial relationships to disclose. Emily Fries has no relevant financial relationships to disclose. Shabana Khan has no relevant financial relationships to disclose. Adam Kozikowski has no relevant financial relationships to disclose. S. Alex Sidelnik has no relevant financial relationships to disclose. Michael Yee has no relevant financial relationships to disclose. David Ginsberg has no relevant financial relationships to disclose. Amanda M. Spray has no relevant financial relationships to disclose. Nikhil A. Patel has no relevant financial relationships to disclose. Ashvin Sood has no relevant financial relationships to disclose. Stephanie X. Wu has no relevant financial relationships to disclose. Naomi M. Simon receives royalties from Wolters Kluwer; consults for Vanda Pharmaceuticals Inc, Massachusetts General Hospital Psychiatry Academy, Axovant Sciences, Springworks, Praxis Therapeutics, Aptinyx, and Genomind; serves as Deputy Editor for the journal Depression and Anxiety; and does contracted research for the American Foundation for Suicide Prevention, the Department of Defense, Patient-Centered Outcomes Research Institute, Highland Street Foundation, National Institutes of Health, and Janssen; receives payments from Wiley-Blackwell for work as the deputy editor of the journal Depression and Anxiety; and her spouse/partner owns stock in G1 Therapeutics. Rachel Podbury has no relevant financial relationships to disclose. Ariela Vasserman has no relevant financial relationships to disclose. Yona Silverman has no relevant financial relationships to disclose. Randi Pochtar has no relevant financial relationships to disclose. Marra G. Ackerman has no relevant financial relationships to disclose. Sharon B. Madanes has no relevant financial relationships to disclose. Rose Levenson-Palmer has no relevant financial relationships to disclose. Kristin L. Szuhany has no relevant financial relationships to disclose. Matteo Malgaroli has no relevant financial relationships to disclose. Emma L. Jennings has no relevant financial relationships to disclose. Deepti Anbarasan has no relevant financial relationships to disclose. Paula Askalsky has no relevant financial relationships to disclose. Rahn K. Bailey has no relevant financial relationships to disclose. Edward M. Kantor has no relevant financial relationships to disclose. Frederick J. Stoddard Jr. receives royalties from Oxford University Press. James C. West has no relevant financial relationships to disclose. Charles R. Marmar has no relevant financial relationships to disclose.

Accreditation statement(s):  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and SLACK Incorporated. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

Credit designation: AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 3.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Release date:  July 1, 2020.  Expiration Date:  August 1, 2023.

How to participate:  To participate in this CME activity, you must read the learning objectives, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, AKH Inc., Advancing Knowledge in Healthcare will issue an AMA PRA Category 1 Credit(s)™ certificate.

Target audience:  This CME activity is primarily targeted to patient-caring psychiatrists, physicians specializing in psychiatry, and others allied to the field. There are no specific background requirements for participants taking this activity.

Unlabeled and investigational usage statement:  The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The authors have been made aware of their obligation to disclose such usage.